AMD Eye Image Library (ABID) Study
Part of Eyes & vision clinical trials.
This study is creating a library of eye images to help doctors better diagnose age-related macular degeneration (AMD). You can join if you have healthy eyes or any stage of AMD that has never been treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 50 years old or older.
- You can have healthy eyes or any stage of age-related macular degeneration (AMD), as long as you have never had treatment for it.
- You must not have severe vision loss that needs urgent surgery.
- You must be willing to have your eyes imaged (like a retina photo) and sign a consent form.
- You cannot have taken part in a study that tested an AMD treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special camera to take pictures of the back of your eye (retina) to see how age-related macular degeneration (AMD) affects everyday activities like reading and recognizing faces. It also compares people with AMD to healthy volunteers to understand the differences.
This study uses artificial intelligence to track changes in the eyes of people with early or intermediate age-related macular degeneration (AMD). It aims to better understand how the disease progresses and may help doctors personalize care.
This study collects immune cells (from a blood sample) from people with certain types of age-related macular degeneration (AMD) and compares how long they live. It may help researchers understand how immune-related changes relate to AMD outcomes.
This study uses specialized eye imaging to track changes in geographic atrophy, a type of vision loss from macular degeneration. Researchers will use new imaging techniques to better understand how this condition progresses and how treatments work.
This study uses a special, high-resolution camera to take detailed pictures of the back of the eye. It is testing the camera's ability to see changes in the retina for people who are healthy or have age-related macular degeneration, diabetic retinopathy, or other conditions that affect autofluorescence patterns.
This study uses eye imaging and other tests to predict if early age-related macular degeneration (AMD) will progress to a more advanced stage. It aims to help doctors identify who might need closer monitoring in the future.
Hear when a new Age-Related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.